← Leaderboards
David H Harpole
Duke University
$3,835,497
Attributed
$8,390,559
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,390,559 · 6
By mechanism
R38$4,378,146 · 2
T32$2,366,664 · 2
R01$1,540,613 · 1
R29$105,136 · 1
Top collaborators
- Scott M Palmer13 shared
- Peter J Allen5 shared
- Mai Elmallah5 shared
- Eun-Sil Shelley Hwang5 shared
- Herbert Kim Lyerly5 shared
- Rachel G Greenberg4 shared
- Sallie R. Permar4 shared
- John H Stewart2 shared
Most similar at Duke University
Same institution · by research overlap
- Matthew J Ellis$25,349,408
- Nenad Bursac$22,509,345
- Dwight D Koeberl$10,403,079
- Dorothy A Sipkins$8,543,606
- Ornit Chiba-Falek$10,818,821
Others in their field
Top investigators on “Translational Research”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$293,499,096
- Steven E Reis · University Of Pittsburgh At Pittsburgh$280,623,952
- David Heimbrook · Leidos Biomedical Research, Inc.$270,029,156
- Gregory H Reaman · National Childhood Cancer Foundation$259,780,965
- Lee Marshall Nadler · Dana-Farber Cancer Inst$240,966,783
Research focus
Translational ResearchClinical ResearchSuccessMedicineOperative Surgical ProceduresClinical TrialsResearch TrainingTraining ProgramsFundingUniversitiesProgramsFacultyInnovationResearch PersonnelClinical TranslationEligibility DeterminationAreaDevelopment PlansDrug KineticsEvaluationApplications GrantsBiomedical ResearchAffectClinic
Grant awards (25)
Duke Research Training Program in Surgical Oncology$373,556
T32 · FY2025 · CA · contact PI
Stimulating Access to Research in Residency (StARR) - NIAID$315,471
R38 · FY2025 · AI · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$314,820
R38 · FY2025 · HL · contact PI
Stimulating Access to Research in Residency (StARR) - NIAID$315,471
R38 · FY2024 · AI · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$308,524
R38 · FY2024 · HL · contact PI
Duke Research Training Program in Surgical Oncology$181,243
T32 · FY2024 · CA · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$314,820
R38 · FY2023 · HL · contact PI
Duke Resident Physician-Scientist Program- NIAID$355,810
R38 · FY2021 · AI
Duke Resident Physician-Scientist Program- NHLBI$339,431
R38 · FY2021 · HL · contact PI
Duke Resident Physician-Scientist Program- NIAID$355,808
R38 · FY2020 · AI
Duke Resident Physician-Scientist Program- NHLBI$344,685
R38 · FY2020 · HL · contact PI
Translational Research in Surgical Oncology$338,434
T32 · FY2020 · CA
Translational Research in Surgical Oncology$373,223
T32 · FY2019 · CA
Duke Resident Physician-Scientist Program- NIAID$355,808
R38 · FY2019 · AI
Duke Resident Physician-Scientist Program- NHLBI$350,114
R38 · FY2019 · HL
Translational Research in Surgical Oncology$446,107
T32 · FY2018 · CA
Duke Resident Physician-Scientist Program- NIAID$353,784
R38 · FY2018 · AI
Duke Resident Physician-Scientist Program- NHLBI$353,600
R38 · FY2018 · HL
Translational Research in Surgical Oncology$441,040
T32 · FY2017 · CA
Translational Research in Surgical Oncology$213,061
T32 · FY2016 · CA
Validating Molecular Signature Risk Models of NSCLC$1
R01 · FY2010 · CA · contact PI
Validating Molecular Signature Risk Models of NSCLC$455,257
R01 · FY2009 · CA · contact PI
Validating Molecular Signature Risk Models of NSCLC$535,358
R01 · FY2007 · CA · contact PI
Validating Molecular Signature Risk Models of NSCLC$549,997
R01 · FY2006 · CA · contact PI
TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE$105,136
R29 · FY2000 · CA